BIO 2018

Scientist working in the lab at Helix. Photo courtesy of Helix. 

By Laura Lovett June 15, 2018
In the last few years consumer genomics has grown in both its offerings and legitimacy. The industry that was once best known for telling clients if they were Italian or Hungarian is now securing its foothold within the healthcare space.    Whether it is uniting women switched at birth 72-years prior or settling neighborly feuds, consumer genomics have caught the public’s interest. The highest...
By Laura Lovett June 8, 2018
The road to digital innovation in the pharma and healthcare space is going to take players across industries — from tech developers and engineers to researchers and clinicians, according to a panel of digital-focused VPs speaking at BIO 2018 in Boston.  Tech is opening up new avenues in research and development, as well as access to data from EHRs and other databases. In the past, the healthcare...

Dr. Daniel Karlin, Greg Plante, Dr. Stephen Wicks, Dr. Zachary Beattie, and Dr. Mahesh Fuldeore

By Jonah Comstock June 8, 2018
Pharma companies are increasingly embracing the use of wearables and other connected devices to streamline and improve data collection in clinical trials. But for all the advantages these devices might have, there also challenges — especially when it comes to data standardization. This week at BIO 2018, Dr. Daniel Karlin, Pfizer’s head of clinical, informatics, regulatory strategy, digital...
By Dave Muoio June 8, 2018
Digital technologies are cementing their place across healthcare, and the pharmaceutical sector is no exception. This week Boston was host to the Biotechnology Innovation Organization’s annual conference, a multi-day gathering of leading pharma and biotech leaders from across the globe. While, admittedly, digital health wasn’t always the primary interest of many attendees and speakers, it was...
By Laura Lovett June 7, 2018
A drug no longer needs to be a tangible object, according to panelist at the BIO 2018 convention in Boston. The way the pharma industry looks at medication is evolving and may be including new tech-focused treatments, such as digital therapeutics. “If you think about the trajectory of medicine what is a drug these days: is it a pill, is it an injection, is it infusion, is it gene therapy? We’ve...
By Laura Lovett June 5, 2018
It’s no secret investors have been pouring billions of dollars into digital health companies, and it seems the life sciences sector has taken notice. Today at BIO 2018 in Boston, a panel of investors sat down to take the pulse of the digital health industry and give their thoughts on the booming (and potentially crowded) market.  “The bottom line is that an immense amount of money has gone into...
читать далее

www.best-mining.com.ua

www.steroid.in.ua/products/tren-enantat-200-geber